X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4439) 4439
Publication (444) 444
Newsletter (75) 75
Book Review (29) 29
Book Chapter (13) 13
Newspaper Article (6) 6
Conference Proceeding (3) 3
Dissertation (3) 3
Magazine Article (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fludarabine (3699) 3699
humans (3159) 3159
hematology (2192) 2192
oncology (1930) 1930
male (1916) 1916
index medicus (1889) 1889
female (1820) 1820
middle aged (1659) 1659
aged (1401) 1401
adult (1294) 1294
vidarabine - analogs & derivatives (1258) 1258
cyclophosphamide (1030) 1030
rituximab (1025) 1025
leukemia, lymphocytic, chronic, b-cell - drug therapy (995) 995
treatment outcome (868) 868
chronic lymphocytic leukemia (863) 863
therapy (834) 834
antineoplastic combined chemotherapy protocols - therapeutic use (778) 778
transplantation (771) 771
chronic lymphocytic-leukemia (673) 673
cancer (635) 635
chemotherapy (632) 632
vidarabine - administration & dosage (597) 597
leukemia (590) 590
antineoplastic agents - therapeutic use (578) 578
aged, 80 and over (529) 529
care and treatment (495) 495
cll (476) 476
immunology (476) 476
prognosis (470) 470
vidarabine - therapeutic use (463) 463
survival (430) 430
adolescent (412) 412
bone-marrow-transplantation (410) 410
leukemia, lymphocytic, chronic, b-cell - pathology (405) 405
stem-cell transplantation (403) 403
disease-free survival (388) 388
stem cells (386) 386
alemtuzumab (367) 367
retrospective studies (367) 367
transplantation conditioning - methods (367) 367
research (357) 357
lymphoma (347) 347
health aspects (342) 342
hematopoietic stem cells (340) 340
transplantation, homologous (332) 332
risk factors (331) 331
apoptosis (319) 319
cyclophosphamide - administration & dosage (317) 317
survival analysis (308) 308
antineoplastic combined chemotherapy protocols - adverse effects (307) 307
remission induction (303) 303
hematology, oncology and palliative medicine (301) 301
survival rate (300) 300
recurrence (297) 297
trial (295) 295
vidarabine - adverse effects (295) 295
leukemia, lymphocytic, chronic, b-cell - mortality (290) 290
hematopoietic stem cell transplantation (287) 287
chlorambucil (283) 283
medicine & public health (276) 276
fludarabine plus cyclophosphamide (266) 266
antineoplastic agents - adverse effects (264) 264
leukemia, lymphocytic, chronic, b-cell - therapy (264) 264
drug therapy (263) 263
stem cell transplantation (262) 262
follow-up studies (260) 260
child (259) 259
antineoplastic agents (258) 258
non-hodgkins-lymphoma (258) 258
analysis (257) 257
dosage and administration (255) 255
young adult (255) 255
antibodies, monoclonal - therapeutic use (250) 250
hematopoietic stem cell transplantation - methods (250) 250
diagnosis (249) 249
leukemia, lymphocytic, chronic, b-cell - genetics (245) 245
pharmacology & pharmacy (239) 239
article (235) 235
busulfan (235) 235
versus-host-disease (228) 228
acute myeloid-leukemia (227) 227
antimitotic agents (227) 227
patients (224) 224
cladribine (223) 223
antineoplastic combined chemotherapy protocols - administration & dosage (219) 219
toxicity (218) 218
phase-ii trial (217) 217
expression (212) 212
animals (208) 208
initial therapy (204) 204
hemic and lymphatic diseases (202) 202
combination (201) 201
regimen (200) 200
antineoplastic agents - pharmacology (198) 198
immunotherapy (197) 197
bone marrow (196) 196
lymphomas (194) 194
vidarabine - pharmacology (193) 193
cytarabine (192) 192
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4388) 4388
French (33) 33
German (32) 32
Polish (18) 18
Russian (18) 18
Spanish (12) 12
Czech (7) 7
Hungarian (6) 6
Korean (6) 6
Chinese (4) 4
Portuguese (3) 3
Slovak (3) 3
Turkish (3) 3
Japanese (2) 2
Romanian (2) 2
Slovenian (2) 2
Dutch (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Eye (Basingstoke), ISSN 0950-222X, 2019, Volume 33, Issue 6, pp. 1023 - 1025
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 04/2019, Volume 12, Issue 1, pp. 44 - 10
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 04/2014, Volume 32, Issue 12, pp. 1236 - 1236
Purpose Most patients with chronic lymphocytic leukemia (CLL) are elderly and/or have comorbidities that may make them ineligible for fludarabine-based... 
TRIAL | THERAPY | ONCOLOGY | CYCLOPHOSPHAMIDE | FLUDARABINE | PREVIOUSLY UNTREATED PATIENTS
Journal Article
Leukemia, ISSN 0887-6924, 08/2000, Volume 14, Issue 8, pp. 1405 - 1413
Fludarabine is a nucleotide analog effective in the clinical treatment of chronic lymphocytic leukemia (CLL) and other indolent lymphocytic malignancies.... 
fludarabine
Journal Article
Blood, ISSN 0006-4971, 10/2018, Volume 132, Issue 15, pp. 1547 - 1548
In this issue of Blood, Rogers et al demonstrate that 3 novel agents approved for chronic lymphocytic leukemia (CLL), ibrutinib, venetoclax, and obinutuzumab,... 
HEMATOLOGY | CYCLOPHOSPHAMIDE | FLUDARABINE | VENETOCLAX | RITUXIMAB
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2019, Volume 184, Issue 3, pp. 322 - 322
Journal Article
BLOOD, ISSN 0006-4971, 06/2012, Volume 119, Issue 23, pp. 5591 - 5598
We report the relative efficacy of coinfusing 2 umbilical cord blood units (dUCB) compared with peripheral blood progenitor cells (PBPCs) from 8 of 8 or 7 of 8... 
ADULT PATIENTS | ENGRAFTMENT | BONE-MARROW | MALIGNANCIES | UMBILICAL-CORD BLOOD | ACUTE MYELOID-LEUKEMIA | HEMATOLOGY | FLUDARABINE
Journal Article
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, ISSN 1083-8791, 08/2019
Despite excellent transplant outcomes of aplastic anemia (AA) in developed countries, management in developing countries is challenging because of delay in the... 
Journal Article
BLOOD, ISSN 0006-4971, 07/2017, Volume 130, Issue 3, pp. 376 - 376
Journal Article
Klinicka Onkologie, ISSN 0862-495X, 2018, Volume 31, Issue 4, p. 301
Although chylothorax is rare in patients with malignant lymphoma, it has been reported in cases with mediastinal lymphadenopathy, a bulky retroperitoneal mass,... 
Lymphoma | Chylothorax | Fludarabine
Journal Article
Cancer, ISSN 0008-543X, 11/2013, Volume 119, Issue 21, pp. 3805 - 3811
BACKGROUNDThe combination of fludarabine, cyclophosphamide, and rituximab (FCR) has produced improved response rates and a prolonged survival in patients with... 
chronic lymphocytic leukemia | combination of fludarabine, cyclophosphamide, and rituximab | cytopenia | prognosis | and rituximab | CHEMOIMMUNOTHERAPY | combination of fludarabine | REGIMEN | ACUTE MYELOID-LEUKEMIA | MYELODYSPLASTIC SYNDROME | TRIAL | MAINTENANCE | ONCOLOGY | INITIAL THERAPY | cyclophosphamide | COMBINATION CHEMOTHERAPY | PROGRESSION-FREE | LYMPHOMA | Myeloablative Agonists - therapeutic use | Cyclophosphamide - administration & dosage | Immunotherapy - methods | Myeloablative Agonists - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Young Adult | Aged, 80 and over | Clinical Trials, Phase II as Topic - statistics & numerical data | Adult | Female | Leukemia, Lymphocytic, Chronic, B-Cell - blood | Retrospective Studies | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Immune Tolerance - drug effects | Pancytopenia - chemically induced | Vidarabine - adverse effects | Pancytopenia - diagnosis | Rituximab | Treatment Outcome | Vidarabine - analogs & derivatives | Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology | Immunotherapy - adverse effects | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Pancytopenia - epidemiology | Adolescent | Aged | Vidarabine - administration & dosage | Pancytopenia - blood | Antibodies, Monoclonal, Murine-Derived - adverse effects | Chronic lymphocytic leukemia | Cyclophosphamide | Fludarabine | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
BLOOD, ISSN 0006-4971, 03/2016, Volume 127, Issue 11, pp. 1502 - 1508
The cumulative incidence of National Institutes of Health (NH-)-defined chronic graft versus -host disease (GVHD) requiring systemic treatment is 35% at 1 year... 
MORTALITY | SINGLE-AGENT | PROPHYLAXIS | DIAGNOSIS | STEM-CELLS | BONE-MARROW-TRANSPLANTATION | PILOT PHARMACOLOGICAL BIOMARKER | RECIPIENTS | HEMATOLOGY | FLUDARABINE | BUSULFAN
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 03/2001, Volume 41, Issue 1-2, pp. 137 - 145
Follicular small cell and follicular mixed small and large cell lymphoma (FL) are incurable with conventional chemotherapy, and generally follow a relapsing... 
fludarabine
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.